piribedil

DRUG4 trials

Sponsors

Faculdade de Medicina de Valenca, Desitin Arzneimittel GmbH

Conditions

Idiopathic Parkinson's DiseaseParkinson's DiseaseTinnitus

Phase 3

Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists

CompletedNCT01007864

Desitin Arzneimittel GmbHIdiopathic Parkinson's Disease

Start: 2010-01-31End: 2011-12-31Updated: 2012-05-24

Unknown Phase

Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography

CompletedNCT00591994

Faculdade de Medicina de ValencaTinnitus

Start: 2006-11-30Updated: 2008-03-07

SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease

CompletedNCT00725478

Desitin Arzneimittel GmbHParkinson's Disease

Start: 2008-01-31End: 2008-06-30Updated: 2010-03-31

SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)

CompletedNCT00727727

Desitin Arzneimittel GmbHParkinson's Disease

Start: 2008-03-31End: 2008-12-31Target: 750Updated: 2009-02-25